this was a placebocontrolled doubleblind study designed to evaluate the effect of a commercially available dietary supplement on upperrespiratory tract symptoms urti and mood stateseventyfive marathon runners 35 men 40 women ranging in age from 1853 years mean age 36  9 selfadministered placebo 250 mg or 500 mg of beta 1316 glucan commercial name wellmune wgp daily during the 4 week postmarathon trial period following the 2007 carlsbad marathonsubjects filled out the profile of mood state poms assessment and a questionnaire style health log measuring health status and urti symptoms after 2 and 4week treatment administrationsduring the course of the 4week study subjects in the treatment groups 250 mg and 500 mg betaglucan per day reported significantly fewer urti symptoms better overall health and decreased confusion fatigue tension and anger and increased vigor based on the poms survey compared to placebobetaglucan may prevent urti symptoms and improve overall health and mood following a competitive marathonkey points